US EditionPublished • loading... • Updated
Eli Lilly loses appeal of $183.7 million Medicaid fraud award
Eli Lilly's decade-long pricing scheme concealed retroactive drug price increases, causing over $60 million underpayment to Medicaid, affirmed by the 7th Circuit Court.
- A federal appeals court rejected Eli Lilly's appeal of a $183.7 million judgment for defrauding Medicaid by concealing retroactive price increases on drugs.
- Lilly required wholesalers to pay more for drugs already purchased if prices increased, but reported original lower prices for Medicaid rebates.
- The court said there was 'ample evidence' Lilly disregarded the risk of violating the law and obfuscated facts to deprive the government of over $60 million.
Insights by Ground AI
9 Articles
9 Articles
Eli Lilly Loses Appeal of $183.7 Million Medicaid Fraud Award
·New York, United States
Read Full Article
Eli Lilly Loses Multi-Million Dollar Appeal In Medicaid Fraud Case
Drug giant’s “common-sense” price scheme ruled illegal by federal court, upholding over $183 million in damages. The United States Court of Appeals for the Seventh Circuit has affirmed a landmark jury verdict against pharmaceutical titan Eli Lilly on Thursday, forcing the company to pay over $183 million for defrauding the government’s Medicaid program. The ruling, […] Eli Lilly Loses Multi-Million Dollar Appeal In Medicaid Fraud Case
·Tampa, United States
Read Full ArticleCoverage Details
Total News Sources9
Leaning Left1Leaning Right2Center5Last UpdatedBias Distribution63% Center
Bias Distribution
- 63% of the sources are Center
63% Center
13%
C 63%
R 25%
Factuality
To view factuality data please Upgrade to Premium
